Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

Wu J, Peng L, McMahon GA, Lawrence DA, Fay WP.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1565-70. doi: 10.1161/ATVBAHA.109.189514. Epub 2009 Jul 2.


Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.

Stefansson S, Yepes M, Gorlatova N, Day DE, Moore EG, Zabaleta A, McMahon GA, Lawrence DA.

J Biol Chem. 2004 Jul 16;279(29):29981-7. Epub 2004 May 6.


Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.

Stefansson S, McMahon GA, Petitclerc E, Lawrence DA.

Curr Pharm Des. 2003;9(19):1545-64. Review.


Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophages.

Curino A, Mitola DJ, Aaronson H, McMahon GA, Raja K, Keegan AD, Lawrence DA, Bugge TH.

Oncogene. 2002 Dec 12;21(57):8830-42.


Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis.

McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA.

J Biol Chem. 2001 Sep 7;276(36):33964-8. Epub 2001 Jul 5.


Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1.

Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC, Lawrence DA.

J Biol Chem. 2001 Mar 16;276(11):8135-41. Epub 2000 Nov 16.


An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro.

Zimrin AB, Pepper MS, McMahon GA, Nguyen F, Montesano R, Maciag T.

J Biol Chem. 1996 Dec 20;271(51):32499-502.


Supplemental Content

Loading ...
Support Center